The Journal of Organic Chemistry
Article
following the general procedure. The crude product was purified by
flash column chromatography (hexane:ethyl acetate, 1:1 with 1%
NEt3) to obtain compound 20 as a syrup (165 mg, 86%): H NMR
2H, H3, H4), 4.97−4.90 (m, 2H, H2), 4.61 (dd, J = 7.8/9.6 Hz, 1H,
H1), 4.00−3.65 (m, 10H, 2 × OCH2, OCH2CH2CN, CH3O, H5),
3.60−3.48 (m, 2H, 2 × CHisopropyl), 2.59−2.55 (m, 2H, CH2CN), 2.04,
1
(300 MHz, CDCl3) δ 5.25−5.16 (m, 2H, H2, H3), 4.99 (t, J = 9.9 Hz,
1H, H4), 4.71 (dd, J = 3.7/1.6 Hz, 1H, H1), 3.94−3.48 (m, 9H, 2 ×
OCH2, OCH2CH2CN, 2 × CHisopropyl, H5), 2.63−2.57 (m, 2H,
CH2CN), 2.07, 1.98, 1.91 (3s, 3H, 3 × OCOCH3), 1.19−1.11 (m,
15H, CH3, 4 × CH3isopropyl); 13C NMR (75 MHz, CDCl3) δ = 170.1,
170.0, 169.9 (CO), 117.8 (CN), 97.7 (C1), 71.1, 69.7, 69.0, 67.8, 67.5,
63.3, 62.4, 62.2, 58.5, 43.2 (NCHisopropyl), 24.6, 24.5 (CH3isopropyl), 20.9,
20.8 (OCCH3), 20.6 (CH2CN), 17.4 (CH3); HRMS (FAB+) Calcd.
for C23H39N2O10PNa (M + Na) 557.2240, found 557.2222.
2-(2,3,4-Tri-O-acetyl-β-D-xylopyranosyloxy)ethyl(2-cyanoethyl)-
(N,N-diisopropyl)phosphoramidite (23). 2-Hydroxyethyl 2,3,4-tri-O-
acetyl-β-D-xylopyranose 22 (0.06 g, 0.197 mmol) was reacted
following the general procedure. The crude product was purified by
silica gel column chromathography (hexane:ethyl acetate, 1:1 with 1%
NEt3) to give compound 23 as a syrup (80 mg, 83%): 1H NMR (300
MHz, CDCl3) δ ppm 5.08 (t, J = 8.5 Hz, 1H, H3), 4.88−4.82 (m, 2H,
H2, H4), 4.51 (m, 1H, H1), 4.06 (dd, J = 5.3/11.8 Hz, 1H, H5), 3.89−
3.46 (m, 8H, 2 × OCH2, OCH2CH2CN, 2 × CHisopropyl), 3.34−3.26
(m, 1H, H5′), 2.61−2.54 (m, 2H, CH2CN), 1.99, 1.98, 1.97 (3s, 9H, 3
× OCOCH3), 1.11, 1.10 (2d, 12H, 4 × CH3isopropyl); 13C NMR (75
MHz, CDCl3) δ = 170.1, 169.9, 169.4 (3 × CO), 117.7 (CN), 100.7
(C1), 71.4, 70.6, 69.1, 68.8, 62.5, 62.3, 61.9, 58.5, 58.3, 43.1
(NCHisopropyl), 24.6, 24.5 (CH3isopropyl), 20.8, 20.6 (OCCH3), 20.5
(CH2CN); HRMS (FAB+) Calcd. for C22H37KN2O10P (M + K)
559.1823, found 559.1827.
2-(2,3,4-Tri-O-acetyl-6-deoxy-β-D-glucopyranosyloxy)ethyl(2-
cyanoethyl)(N,N-diisopropyl)phosphoramidite (26). 2-Hydroxyethyl
2,3,4-tri-O-acetyl-6-deoxy-β-D-glucopyranoside 25 (0.140 g, 0.418
mmol) was reacted following the general procedure. The crude
product was purified by silica gel column chromathography using as
eluent (hexane:ethyl acetate, 1:1 with 1% NEt3) to give compound 26
as a syrup (200 mg, 90%): 1H NMR (500 MHz, CDCl3) δ 4.90 (t, J =
9.6 Hz, 1H, H3), 4.74−4.680 (m, 1H, H2), 4.57 (t, J = 9.6 Hz, 1H, H4),
4.36 (dd, JH,P= 14.5, J = 8.1 Hz, 1H, H1), 3.70−3.40 (m, 6H, 2 ×
OCH2, OCH2CH2CN), 3.39−3.29 (m, 3H, 2 × CHisopropyl, H5), 2.67−
2.62 (m, 2H, CH2CN), 2.05, 2.03, 1.99 (3s, 3H, 3 × OCOCH3), 1.23
(d, 3H, J = 6.0 Hz, CH3), 1.17 (t, 12H, 4CH3isopropyl); 13C NMR (75
MHz, CDCl3) δ = 170.2, 169.9, 169.6 (CO), 118.0 (CN), 100.8 (C1),
73.6 (C4), 73.1 (C3), 71.9 (C2), 70.2 (C5), 69.5, 62.8, 58.7 (3 × CH2),
43.3 (NCHisopropyl), 25.0, 24.9, 24.8, 24.7 (CH3isopropyl), 21.0, 20.9, 20.8
(OCCH3), 20.6 (CH2CN), 17.6 (CH3); HRMS (FAB+) Calcd. for
C23H39N2O10PNa (M + Na) 557.2240, found 557.2243.
2-(3,4,6-Tri-O-acetyl-2-acetamido-2-deoxy-β-D-glucopyrano-
syloxy)ethyl(2-cyanoethyl)(N,N-diisopropyl)phosphoramidite (31).
2-Hydroxyethyl 3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-β-D-glucopyra-
noside 30 (0.20 g, 0.50 mmol) was reacted following the general
procedure. The crude product was purified by silica gel column
chromathography (hexane:ethyl acetate, 1:1 with 1% NEt3) to give
compound 31 as a syrup (265 mg, 90%): 1H NMR (300 MHz,
CDCl3) δ 5.92 (dd, J = 3.0/8.7 Hz, 1H, NH), 4.96 (t, J = 9.6 Hz, 1H,
H3), (td, J = 2.7/9.6 Hz, 1H, H4), 4.61 (t, J = 8.4 Hz, 1H, H1), 3.98
(dd, J = 4.8/12.3 Hz, 1H, H6), 3.84 (dd, J = 2.7/12.3 Hz, 1H, H6′),
3.72−3.40 (m, 9H, 2 × OCH2, OCH2CH2CN, H2, H5), 3.37−3.26 (m,
2H, 2 × CHisopropyl), 2.43−2.39 (m, 2H, CH2CN), 1.81, 1.73, 1.67 (3s,
12H, 3 × OCOCH3), 0.92−0.89 (m, 12H, 4 × CH3isopropyl); 13C NMR
(75 MHz, CDCl3) δ = 170.9, 170.6, 169.6 (CO), 118.4 (CN), 101.3
(C1), 73.0 (C3), 72.0 (C4), 69.6, 68.9 (CH2), 62.9 (CH2), 62.4 (C6),
58.5 (CH2), 54.6 (C2), 43.3 (NCHisopropyl), 24.9 (CH3isopropyl), 21.0,
20.9, 20.8 (OCCH3), 20.7 (CH2CN); HRMS (FAB+) Calcd. for
C25H42N3NaO11P (M + Na) 614.2455, found 614.2440.
1.99 (2s, 9H, 3 xOCOCH3), 1.15−1.09 (m, 12H, 4 × CH3isopropyl); 13
C
NMR (100 MHz, CDCl3) δ = 170.1, 169.4, 169.3, 167.2 (4 × CO),
117.8 (CN), 100.8 (C1), 72.5 (C5), 72.0 (C3), 71.1 (C2), 69.6 (CH2),
69.4 (C4), 62.4, 58.5, 52.8 (3 × CH2), 43.0 (NCHisopropyl), 24.6, 24.5
(CH3isopropyl), 20.7, 20.5, 20.4 (OCCH3), 20.3 (CH2CN); HRMS
(FAB+) Calcd. for C24H39N2O12PNa (M + Na) 601.2134, found
601.2138.
2-(2,3,4-Tri-O-methyl-6-O-acetyl-β-D-glucopyranosyloxy)ethyl(2-
cyanoethyl)(N,N-diisopropyl)phosphoramidite (41). 2-Hydroxyethyl
2,3,4-tri-O-methyl-6-O-acetyl-β-D-glucopyranose 40 (165 mg, 0.535
mmol) was reacted following the general procedure. The crude
product was purified by silica gel column chromatography
(hexane:ethyl acetate, from 3:2 to 1:2 with 1% NEt3) to give
1
compound 41 as a white foam (155 mg, 57%): H NMR (400 MHz,
CDCl3) δ ppm 4.30−4.20 (m, 2H, H6′, H1), 4.13 (dd, 1H, H6), 3.90
(m, 1H, CH2), 3.85−3.73 (m, 3H, CH iPr, CH2), 3.67 (dtt, 2H, CH2),
3.55 (s, 5H, OCH3+2H), 3.51 (s, 3H, OCH3), 3.44 (s, 3H, OCH3),
3.30 (ddd, 1H, H5), 3.10 (t, 1H, H3), 3.02 (t, 1H, H4), 2.92 (ddd, 1H,
H2), 2.58 (t, 2H, CH2), 2.02 (s, 3H, OCOCH3), 1.14−1.08 (m, 12H,
4 × CH3 isopropyl); 13C NMR (101 MHz, CDCl3) δ = 170.8 (CO),
117.7 (CN), 103.5 (C1), 86.3, 83.6, 79.4, 72.7, 69.6 (dd), 63.3, 62.4
(dd), 60.8, 60.6−60.2 (m, 2C), 58.4 (dd), 43.0 (dd, 2C), 24.7−24.4
(m, 4C), 20.8, 20.3; HRMS (FAB+) Calcd. for C22H42N2O9P (M + H)
509.2628, found 509.2653.
2-(2,3-Di-O-acetyl-4,6-di-O-methyl-β-D-glucopyranosyloxy)ethyl-
(2-cyanoethyl)(N,N-diisopropyl)phosphoramidite (44). 2-Hydrox-
yethyl 2,3-di-O-acetyl-4,6-di-O-methyl-β-D-glucopyranose 43 (0.150
g, 0.45 mmol) was reacted following the general procedure. The crude
product was purified by silica gel column chromathography
(hexane:ethyl acetate, 1:1 with 1% NEt3) to give compound 44 as a
white foam (111 mg, 53%): 1H NMR (400 MHz, CDCl3) δ ppm 5.14
(m, 1H, H3), 4.89 (ddd, 1H, H2), 4.55 (dd, 1H, H1), 3.98 (m, 2H,
CH2), 3.83 (m, 2H, CH2), 3.73 (m, 2H, CH2), 3.68−3.56 (m, 5H, H5,
H6/H6′, 2 × CHisopropyl), 3.48−3.40 (m, 7H, H4, 2 × OCH3), 2.66 (m,
2H, CH2), 2.06 (m, 6H, 2 × OCOCH3), 1.19 (m, 12H, 4 ×
CH3isopropyl); 13C NMR (101 MHz, CDCl3) δ = 170.2, 169.7 (CO),
117.8 (CN), 100.7 (C1), 75.1, 74.7, 71.9, 70.8, 69.3, 69.1, 62.5, 62.3,
60.3, 59.4, 58.6, 58.4, 43.1, 43.0, 24.7, 24.6, 24.5, 20.8, 20.4; HRMS
(FAB+) Calcd. for C23H41N2O10PNa (M + Na) 559.2392, found
559.2397.
2-(2,4,6-Tri-O-acetyl-3-deoxy-3-fluoro-β-D-glucopyranosyloxy)-
ethyl(2-cyanoethyl)(N,N-diisopropyl)phosphoramidite (47). 2-Hy-
droxyethyl 2,4,6-tri-O-acetyl-3-deoxy-3-fluoro-β-D-glucopyranose 46
(0.220 g, 0.62 mmol) was reacted following the general procedure.
The crude product was purified by silica gel column chromathography
(hexane:ethyl acetate, from 3:2 to 1:1 with 1% NEt3) to give
compound 47 as a syrup (260 mg, 76%): 1H NMR (300 MHz,
CDCl3) δ ppm 5.11−4.91 (m, 2H, H4, H2), 4.53−4.28 (m, 2H, H1,
H3), 4.12 (ddd, J= 2.0/4.7/12.4 Hz, 1H, H6), 3.99 (br. d, J= 12.3 Hz,
1H, H6′), 3.86−3.53 (m, 6H, 2 × OCH2, OCH2CH2CN) 3.52−3.40
(m, 3H, 2 × CHisopropyl, H5), 2.53−2.49 (m, 2H, CH2CN), 1.99, 1.97,
1.96 (s, 9H, 3 × OCOCH3), 1.05, 1.03 (2d, 12H, 4CH3isopropyl); 13C
NMR (75 MHz, CDCl3) δ = 170.9, 169.5, 169.4 (CO), 118.0 (CN),
101.0 (d, JC,F = 10.65 Hz, C1), 91.9 (d, JC,F = 189.1 Hz, C3), 71.4 (d,
JC,F = 18.5 Hz, C2), 71.1 (d, JC,F = 7.65 Hz, C5), 69.8 (CH2), 68.5 (d,
JC,F = 18.3 Hz, C4), 62.6 (CH2), 62.0 (C6), 58.6 (CH2), 43.3
(NCHisopropyl), 24.9, 24.8 (CH3 isopropyl), 21.1, 21.0, 20.9 (OCCH3),
20.6 (CH2CN). 19F NMR (CDCl3, 323.6 MHz, internal reference
TFT) −195.3 ppm; HRMS (FAB+) Calcd. for C23H38N2O10FNaP (M
+ Na) 575.2146, found 575.2158.
2-(Methyl 2,3,4-tri-O-acetyl-β-D-glucopyranosyluronate-oxy)-
ethyl(2-cyanoethyl)(N,N-diisopropyl)phosphoramidite (35). 2-Hy-
droxyethyl methyl 2,3,4-tri-O-acetyl-β-D-glucopyranosyluronate 34
(0.14 g, 0.37 mmol) was reacted following the general procedure.
The crude product was purified by silica gel column chromathography
(hexane:ethyl acetate, 1:1 with 1% NEt3) to give compound 35 as a
2-(2,3,6-Tri-O-acetyl-4-deoxy-4-fluoro-β-D-glucopyranosyloxy)-
ethyl(2-cyanoethyl)(N,N-diisopropyl)phosphoramidite (50). 2-Hy-
droxyethyl 2,3,6-tri-O-acetyl-4-deoxy-4-fluoro-β-D-glucopyranose 49
(0.365 g, 1.036 mmol) was reacted following the general procedure.
The crude product was purified by silica gel column chromathography
(hexane:ethyl acetate, from 3:2 to 1:1 with 1% NEt3) to give
compound 50 as a syrup (434 mg, 76%): 1H NMR (300 MHz,
1
syrup (160 mg, 75%): H NMR (300 MHz, CDCl3) δ 5.21−5.11 (m,
2427
dx.doi.org/10.1021/jo402700y | J. Org. Chem. 2014, 79, 2419−2429